NO20043735L - Anvendelse av acylaminoalkenylenamidderivater ved funksjonelle motilitetsforstyrrrelser i innvollene - Google Patents

Anvendelse av acylaminoalkenylenamidderivater ved funksjonelle motilitetsforstyrrrelser i innvollene

Info

Publication number
NO20043735L
NO20043735L NO20043735A NO20043735A NO20043735L NO 20043735 L NO20043735 L NO 20043735L NO 20043735 A NO20043735 A NO 20043735A NO 20043735 A NO20043735 A NO 20043735A NO 20043735 L NO20043735 L NO 20043735L
Authority
NO
Norway
Prior art keywords
acylaminoalkenylenamide
intestines
derivatives
motility disorders
functional motility
Prior art date
Application number
NO20043735A
Other languages
English (en)
Inventor
John R Fozard
Hans-Juergen Pfannkuche
Weber Eckhard
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of NO20043735L publication Critical patent/NO20043735L/no

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/16Amides, e.g. hydroxamic acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/10Laxatives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12Antidiarrhoeals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • A61P13/10Drugs for disorders of the urinary system of the bladder

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Urology & Nephrology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Nutrition Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Indole Compounds (AREA)
NO20043735A 2002-02-08 2004-09-07 Anvendelse av acylaminoalkenylenamidderivater ved funksjonelle motilitetsforstyrrrelser i innvollene NO20043735L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0203061.7A GB0203061D0 (en) 2002-02-08 2002-02-08 Organic compounds
PCT/EP2003/001227 WO2003066062A1 (en) 2002-02-08 2003-02-07 Use of acylaminoalkenylene-amide derivatives in functional motility disorders of the viscera

Publications (1)

Publication Number Publication Date
NO20043735L true NO20043735L (no) 2004-09-07

Family

ID=9930743

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20043735A NO20043735L (no) 2002-02-08 2004-09-07 Anvendelse av acylaminoalkenylenamidderivater ved funksjonelle motilitetsforstyrrrelser i innvollene

Country Status (19)

Country Link
US (2) US20050203164A1 (no)
EP (2) EP1476167A1 (no)
JP (2) JP2005516994A (no)
KR (2) KR20100100994A (no)
CN (1) CN1301714C (no)
AU (1) AU2003244446B2 (no)
BR (1) BR0307479A (no)
CA (1) CA2471964A1 (no)
GB (1) GB0203061D0 (no)
HK (1) HK1077749A1 (no)
IL (2) IL162816A0 (no)
MX (1) MXPA04007640A (no)
NO (1) NO20043735L (no)
NZ (1) NZ534231A (no)
PL (1) PL370255A1 (no)
RU (1) RU2353356C2 (no)
TW (1) TWI330177B (no)
WO (1) WO2003066062A1 (no)
ZA (1) ZA200404960B (no)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0203061D0 (en) * 2002-02-08 2002-03-27 Novartis Ag Organic compounds
AU2004283038B9 (en) * 2003-10-27 2008-04-24 Novartis Ag Use of neurokinin antagonists in the treatment of urinary incontinence
US20080234345A1 (en) 2006-09-08 2008-09-25 Gene Logic Inc. Method for reducing or alleviating inflammation in the digestive tract

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5217996A (en) * 1992-01-22 1993-06-08 Ciba-Geigy Corporation Biaryl substituted 4-amino-butyric acid amides
US5457101A (en) * 1994-06-03 1995-10-10 Eli Lilly And Company Thieno[1,5]benzoidiazepine use
EP0810991B1 (en) * 1995-02-22 1999-04-14 Novartis AG 1-aryl-2-acylamino-ethane compounds and their use as neurokinin especially neurokinin 1 antagonists
CR5278A (es) * 1995-03-24 1996-07-04 Lilly Co Eli Formulacion oral de 2-metil-tieno-benzodiacepina
GB9525296D0 (en) * 1995-12-11 1996-02-07 Merck Sharp & Dohme Therapeutic agents
MY132550A (en) * 1996-08-22 2007-10-31 Novartis Ag Acylaminoalkenylene-amide derivatives as nk1 and nk2 antogonists
GB9708484D0 (en) * 1997-04-25 1997-06-18 Merck Sharp & Dohme Therapeutic agents
IL133357A (en) * 1997-07-02 2003-12-10 Merck & Co Inc Polymorphic form of the tachykinin receptor antagonist 2-(r)-(1-(r)- (3,5-bis(trifluoromethyl) phenyl) ethoxy)-3-(s)-(4-fluoro) phenyl-4- (3-5(-oxo-1h, 4h-1,2,4-triazolo) methylmorpholine
TW520370B (en) * 1998-11-20 2003-02-11 Meiji Seika Kaisha Benzooxazole derivatives and a pharmaceutical composition containing the derivatives as an active ingredient
GB0010958D0 (en) 2000-05-05 2000-06-28 Novartis Ag Organic compounds
WO2002051440A1 (fr) * 2000-12-22 2002-07-04 Takeda Chemical Industries, Ltd. Medicaments de combinaison
GB0203061D0 (en) * 2002-02-08 2002-03-27 Novartis Ag Organic compounds

Also Published As

Publication number Publication date
AU2003244446A1 (en) 2003-09-02
WO2003066062A1 (en) 2003-08-14
NZ534231A (en) 2007-02-23
JP2010241835A (ja) 2010-10-28
MXPA04007640A (es) 2004-11-10
PL370255A1 (en) 2005-05-16
GB0203061D0 (en) 2002-03-27
US20050203164A1 (en) 2005-09-15
EP1476167A1 (en) 2004-11-17
KR20100100994A (ko) 2010-09-15
CN1301714C (zh) 2007-02-28
CA2471964A1 (en) 2003-08-14
TW200302818A (en) 2003-08-16
EP2216025A2 (en) 2010-08-11
ZA200404960B (en) 2006-05-31
BR0307479A (pt) 2004-12-07
CN1627947A (zh) 2005-06-15
JP2005516994A (ja) 2005-06-09
IL162816A (en) 2010-11-30
KR20040081492A (ko) 2004-09-21
AU2003244446B2 (en) 2006-08-10
IL162816A0 (en) 2005-11-20
US20070293473A1 (en) 2007-12-20
TWI330177B (en) 2010-09-11
HK1077749A1 (en) 2006-02-24
RU2004127132A (ru) 2005-06-10
EP2216025A3 (en) 2010-11-10
RU2353356C2 (ru) 2009-04-27

Similar Documents

Publication Publication Date Title
DE60328671D1 (de) Neue aminobenzamidderivate
DK1551802T3 (da) Indol-3-svovlderivater
DK1474408T3 (da) N-Phenyl-2-pyrimidinaminderivater
IS8180A (is) Nýjar besímídasólafleiður
DK1594840T3 (da) Piperidin-benzensulfonamid-derivater
NO20052894D0 (no) 4-tetrazolyl-4-fenylpiperidin-derivater for behandling av smerte
NO20043696L (no) Gamma-sekretaseinhibitorer
IS8352A (is) Ný rópínírólsamsetning
ATE352550T1 (de) Chinazolinderivate
IS8364A (is) N-þíasól-2-ýl-bensamíð afleiður
ATE395345T1 (de) Imidazol-4-yl-ethynyl-pyridin-derivate
ATE512148T1 (de) Pyrazolo- und imidazopyrimidinderivate
DK1487828T3 (da) Morpholinyl-urea-derivater til anvendelse til behandling af inflammatoriske sygdomme
BRPI0312048A2 (pt) conjunto para redução de dobras
PL1786759T3 (pl) Nowe pochodne 3,5-seko-4-norcholestanowe i ich zastosowanie
ATE449064T1 (de) Amidoacetonitrilderivate
DE60321998D1 (de) Optometrisches Instrument
NO20043735L (no) Anvendelse av acylaminoalkenylenamidderivater ved funksjonelle motilitetsforstyrrrelser i innvollene
DE10394115D2 (de) Schabewärmetauscher
IS7906A (is) Afleiður própargýl-tríflúorómetoxý-amínó-benzóþíazóls
HUP0203929D0 (en) New use of substituted alkyl-piridazinone derivatives
FR2856260B1 (fr) Cadre de lit
FR2858206B1 (fr) Extensiometre de la peau
DOP2003000677A (es) Derivados benzofurado y benzotiofeno utiles en el tratamiento de desordenes hiper-proliferativos
UA7131S (uk) Рушникова сушарка

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application